Analyses of the in Vivo Trafficking of Stoichiometric Doses of an Anti-Complement Receptor 1/2 Monoclonal Antibody Infused Intravenously in Mice

Journal of Immunology - United States
doi 10.4049/jimmunol.173.4.2297
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

In Vivo Imaging of Single Quantum Dots Conjugated With Monoclonal Anti-Her2 Antibody in Tumors of Mice

Journal of the Visualization Society of Japan
2006English

Complement-Mediated Mechanisms in Anti-Gd2 Monoclonal Antibody Therapy of Murine Metastatic Cancer

Cancer Research
Cancer ResearchOncology
2005English

Intratibial Injection of an Anti-Doxorubicin Monoclonal Antibody Prevents Drug-Induced Myelotoxicity in Mice

British Journal of Cancer
Cancer ResearchOncology
1997English

Probing of the Expression of the Low-Density Lipoprotein Receptorin Vivousing an Anti-Receptor Monoclonal Antibody

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1991English

The Role of the T-Cell Receptor in Thymocyte Maturation: Effects in Vivo of Anti-Receptor Antibody.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

Phase 1 Experience With an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Therapeutic Effects of Anti-Hmgb1 Monoclonal Antibody on Pilocarpine-Induced Status Epilepticus in Mice

Scientific Reports
Multidisciplinary
2017English

Anti-Il-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection Than Anti-TNF- Antibody in Mice

Clinical and Developmental Immunology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy